Canary Medical secured US $26M tranched financing with Quark Ventures, BioScience Managers and Relentless Pursuit Partners’ Venture Fund.
Asia Cannabis, a licensee of InPlanta technology in the cannabis and hemp industries for Asia, filed for $1.25M IPO on CSE
Quinsam Capital announced eight new investments: FLRish, Acreage Holdings, Medicinal Compassion Canni Farms, King and Pegahmagabow, Ancient Strains, Green Stripe, Xtraction Services, Therma-Bright
iAnthus Capital Holdings (CSE: IAN, OTCQB: ITHUF) secured US $50M investment from New York City based private equity firm Gotham Green Partners
Eli Lilly and Company to acquire 100% of AurKa Pharma from TVM Capital Life Science, acquiring 100% of oncology compound AK-01 which was sold to TVM in 2016.
Canopy Growth (TSX: WEED) to acquire remaining 33.33% stake of BC Tweed Joint Venture Inc. from Victor Krahn, owner SunSelect Produce, for up to $374 million
Aurora Cannabis (TSX: ACB) to acquire all of the issued and outstanding common shares of MedReleaf (TSX: LEAF) in an all-share transaction valued at $3.2B on a fully diluted basis
Natura Naturals, ACMPR licensed grower, closed a round of private financing
Cannabis data and analytics company, Strainprint Technologies closed US $3M private financing led by Cesare Fazari
Los Angeles, CA based MM Enterprises USA (MedMen) entered binding RTO LOI with Ladera Ventures (TSX-V: LV.H) to go public on CSE
Resverlogix Corp. (TSX: RVX) completed US $30 million senior secured loan with Third Eye Capital.
Pangaea Ventures backed Aspect Biosystems received $1M funding from Genome BC.